Merit Medical Systems Inc
0 DAYS LEFT TO SEEK LEAD PLAINTIFF STATUS
Case Summary | |
Company Name: | Merit Medical Systems Inc |
Stock Symbol : | NYSE: MMSI |
Class Period Start: | 02/26/2019 |
Class Period End: | 10/30/2019 |
Lead Plaintiff motion: | 02/03/2020 |
Date Filed: | 12/02/2019 |
Type of Case: | Securities Class Action |
Court: | U.S. District Court for the Central District of California |
Summary: | Thieler Law Corp advises investors with losses exceeding $100,000 of the February 3, 2020 lead plaintiff deadline in a class action lawsuit filed against Merit Medical Systems Inc (NYSE: MMSI) (“Merit Medical” or “the Company”). The suit is pending in the U.S. District Court for the Central District of California and investors, who purchased Merit Medical Systems Inc securities between February 26, 2019 and October 30, 2019, have until February 3, 2020 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class. If you purchased Merit Medical Systems Inc securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class. The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions, reduced sales, and were months behind schedule; sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis; and as a result, Merit Medical’s public statements were materially false and misleading at all relevant times. On October 30, 2019, Merit announced disappointing financial results for the third quarter of 2019, reduced FY 2019 guidance again, and entirely withdrew 2020 guidance. Management attributed the results in part to the summer quarter generally being the slowest quarter of the year. Following this news, Merit Medical's stock price dropped causing investors harm. If you were negatively impacted by your investment in Merit Medical Systems Inc securities between February 26, 2019 and October 30, 2019 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation. Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law. Thieler Law Corp 2534 State Street - Suite 406, San Diego, CA 92101 by email: mail@thielerlaw.com or telephone at +1 (619) 377 - 4324 or visit our website http://www.thielerlaw.com/ or Facsimile: +1 (619) 785 – 3185 |